Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis

OBJECTIVE: To evaluate pathological complete response as a surrogate endpoint for disease-free survival and overall survival in regulatory neoadjuvant trials of early stage breast cancer. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Embase, and Scopus to 1 December 2020. ELIGI...

Descripción completa

Detalles Bibliográficos
Autores principales: Conforti, Fabio, Pala, Laura, Sala, Isabella, Oriecuia, Chiara, De Pas, Tommaso, Specchia, Claudia, Graffeo, Rossella, Pagan, Eleonora, Queirolo, Paola, Pennacchioli, Elisabetta, Colleoni, Marco, Viale, Giuseppe, Bagnardi, Vincenzo, Gelber, Richard D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689398/
https://www.ncbi.nlm.nih.gov/pubmed/34933868
http://dx.doi.org/10.1136/bmj-2021-066381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689398/
https://www.ncbi.nlm.nih.gov/pubmed/34933868
http://dx.doi.org/10.1136/bmj-2021-066381

Ejemplares similares